131 related articles for article (PubMed ID: 8299367)
41. Clobetasone butyrate compared with betamethasone valerate in the treatment of atopic and contact dermatitis.
Fredriksson T; Nordin K
Curr Med Res Opin; 1979; 6(5):322-4. PubMed ID: 540522
[TBL] [Abstract][Full Text] [Related]
42. Topical corticosteroid preparations. Hazards and side-effects.
Macdonald A
Br J Clin Pract; 1971 Sep; 25(9):421-5. PubMed ID: 4255856
[No Abstract] [Full Text] [Related]
43. Corticosteroids induce proliferation but do not influence TNF- or IL-1 beta-induced ICAM-1 expression of human dermal microvascular endothelial cells in vitro.
Hettmannsperger U; Tenorio S; Orfanos CE; Detmar M
Arch Dermatol Res; 1993; 285(6):347-51. PubMed ID: 8105755
[TBL] [Abstract][Full Text] [Related]
44. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
Marks R
Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
[TBL] [Abstract][Full Text] [Related]
45. Incidental finding of skin deposits of corticosteroids without associated granulomatous inflammation: report of three cases.
Joshi R
Indian J Dermatol Venereol Leprol; 2008; 74(1):44-6. PubMed ID: 18187824
[TBL] [Abstract][Full Text] [Related]
46. Commercial glucocorticoid formulations and skin dryness. Could it be caused by the vehicle?
Korting HC; Kerscher M; Vieluf D; Mehringer L; Megele M; Braun-Falco O
Acta Derm Venereol; 1991; 71(3):261-3. PubMed ID: 1678236
[TBL] [Abstract][Full Text] [Related]
47. Topical retinoic acid does not alter the vasoconstrictive properties of topical corticosteroids in humans.
Schmied C; Saurat JH
Dermatologica; 1991; 182(2):107-11. PubMed ID: 2050230
[TBL] [Abstract][Full Text] [Related]
48. Corticoids and human skin fibroblasts: intracellular specific binding in relation to growth inhibition.
Ponec M; De Kloet ER; Kempenaar JA
J Invest Dermatol; 1980 Oct; 75(4):293-6. PubMed ID: 7430694
[TBL] [Abstract][Full Text] [Related]
49. Allergic reactions to topical desoxymethasone and oral triamcinolone.
Brambilla L; Boneschi V; Chiappino G; Fossati S; Pigatto PD
Contact Dermatitis; 1989 Oct; 21(4):272-4. PubMed ID: 2532114
[No Abstract] [Full Text] [Related]
50. [Effectiveness and complications of treatment with corticosteroid preparations of patients with dermatoses].
Tsyrkunov LP
Vestn Dermatol Venerol; 1987; (3):48-52. PubMed ID: 2955607
[No Abstract] [Full Text] [Related]
51. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin.
Priestley GC
Br J Dermatol; 1978 Sep; 99(3):253-61. PubMed ID: 81679
[TBL] [Abstract][Full Text] [Related]
52. A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation.
Paganelli F; Cardillo JA; Melo LA; Oliveira AG; Skaf M; Costa RA;
Ophthalmology; 2004 Nov; 111(11):2102-8. PubMed ID: 15522378
[TBL] [Abstract][Full Text] [Related]
53. Elevated serum levels of interleukins 5, 6, and 10 in a patient with drug-induced exanthem caused by systemic corticosteroids.
Yawalkar N; Hari Y; Helbing A; von Greyerz S; Kappeler A; Baathen LR; Pichler WJ
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):790-3. PubMed ID: 9810897
[No Abstract] [Full Text] [Related]
54. Erythema-multiforme-like lesions from triamcinolone acetonide.
Valsecchi R; Reseghetti A; Leghissa P; Cologni L; Cortinovis R
Contact Dermatitis; 1998 Jun; 38(6):362-3. PubMed ID: 9687059
[No Abstract] [Full Text] [Related]
55. Intralesional Triamcinolone Acetonide Versus Topical Betamethasone Valearate in the Management of Localized Alopecia Areata.
Devi M; Rashid A; Ghafoor R
J Coll Physicians Surg Pak; 2015 Dec; 25(12):860-2. PubMed ID: 26691357
[TBL] [Abstract][Full Text] [Related]
56. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
[No Abstract] [Full Text] [Related]
57. Soak and smear: an effective treatment for eczematous dermatoses.
Assarian Z; O'Brien TJ; Nixon R
Australas J Dermatol; 2015 Aug; 56(3):215-7. PubMed ID: 25726894
[TBL] [Abstract][Full Text] [Related]
58. Dermatitis following systemic prednisolone: patch testing with prednisolone eye drops.
Harris A; McFadden JP
Australas J Dermatol; 2000 May; 41(2):124-5. PubMed ID: 10812710
[TBL] [Abstract][Full Text] [Related]
59. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy.
Franz TJ; Parsell DA; Halualani RM; Hannigan JF; Kalbach JP; Harkonen WS
Int J Dermatol; 1999 Aug; 38(8):628-32. PubMed ID: 10487457
[TBL] [Abstract][Full Text] [Related]
60. The role of vehicle metamorphosis on triamcinolone acetonide delivery to the skin from microemulsions.
Fantini A; Padula C; Nicoli S; Pescina S; Santi P
Int J Pharm; 2019 Jun; 565():33-40. PubMed ID: 31039388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
